- KELLY KALSCHEUR
This weekly conference focuses on the care of pediatric cardiac patients through case-based discussion, contect-expert presentations, and journal reviews. Learning occurs with the interprofessional team to incorporate best approaches into the practice of the entire care team.
Pediatric cardiologists, cardiothoracic surgeons, pediatric critical care physicians (MD, DO), cardiac nurses (RN, APRN), PAs, and students.
|Luke Lamers, MD, Chair
|Kelly Kalscheur, Coordinator
|Jenna Torgeson, APNP
|In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 ANCC contact hour.
ANCC pharmacotherapeutic contact hours will be calculated and awarded as appropriate per session to meet the needs of advanced practice nurses.
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity, all relevant financial relationships have been mitigated and detailed disclosures are listed below.
* Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
Detailed disclosures will be available prior to the start of the activity.
As a result of participation in this educational series, participants will:
- Be better prepared to use current guidlines, recent evidence and best practice related to diagnoses and treatment of congenital and acquired cardiac disease.
- Increase appropriate application of echocardiogram as a diagnostic and treatment techniques of pediatric heart disease.
- Address lab operations concerns raised during quality study analysis of lab function and develop a plan with the echo lab team to address discrepancies.
- Engage in team-based management of the appropriate application of new diagnostic and treatment techniques to improve pediatric cardiology care.